戻る
「早戻しボタン」を押すと検索画面に戻ります。

今後説明を表示しない

[OK]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 njury and potential treatment strategies for maple syrup urine disease.
2 tress shown to cause encephalopathy in human maple syrup urine disease.
3 chain amino acid metabolism resembling human maple syrup urine disease.
4 patocytes from patients and a mouse model of maple syrup urine disease.
5 henylketonuria, branched chain ketoaciduria (maple syrup urine disease) and homocystinuria, which are
6 t to prevent encephalopathy in children with maple syrup urine disease during catabolic stress.
7 cine, isoleucine, and valine are elevated in maple syrup urine disease, heart failure, obesity, and t
8 metabolic correction of a mouse intermediate maple syrup urine disease (iMSUD) model after allogenic
9 two converging mechanisms of brain injury in maple syrup urine disease including: (i) neurotransmitte
10                                              Maple syrup urine disease is caused by deficiency in the
11 ially delayed encephalopathy in intermediate maple syrup urine disease mice placed on a high protein
12 toacids have been recognized as the cause of maple syrup urine disease (MSUD) for decades, treatment
13                                              Maple syrup urine disease (MSUD) is a metabolic disorder
14                                              Maple syrup urine disease (MSUD) is a rare metabolic dis
15                                              Maple syrup urine disease (MSUD) is a rare, autosomal re
16                                              Maple Syrup Urine Disease (MSUD) is an inherited disorde
17                                              Maple syrup urine disease (MSUD) is an inherited disorde
18                                              Maple syrup urine disease (MSUD) is an inherited disorde
19                                              Maple syrup urine disease (MSUD) or branched-chain alpha
20  that natural mutations of these residues in maple syrup urine disease (MSUD) patients (R114W-alpha a
21                                              Maple syrup urine disease (MSUD) results from mutations
22                                    Untreated maple syrup urine disease (MSUD) results in mental and p
23  intermittent or intermediate types of human maple syrup urine disease (MSUD), a hereditary disorder
24  and cause multiple human diseases including maple syrup urine disease (MSUD), autism, and other rela
25 determined RBC UDPgalactose in patients with maple syrup urine disease (MSUD), phenylketonuria (PKU),
26 with classic and variant late-onset forms of maple syrup urine disease (MSUD).
27                             The nine E1alpha maple syrup urine disease mutants studied showed aberran
28 roach to mitigate assembly defects caused by maple syrup urine disease mutations.
29 orleucine to heterozygous mothers of classic maple syrup urine disease pups reduced branched-chain am
30                     In patients with type IA maple syrup urine disease, the E1alpha subunit is affect
31                                 A child with maple syrup urine disease type 2 (MSUD2) was found to be
32 ped mouse models of classic and intermediate maple syrup urine disease, we assessed biochemical, beha

WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。